Crossmark

Health-related quality of life as an endpoint in oncology phase I trials: a systematic review

Crossref DOI link: https://doi.org/10.1186/s12885-019-5579-3

Published Online: 2019-04-16

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fiteni, Frédéric

Ray, Isabelle Le

Ousmen, Ahmad

Isambert, Nicolas

Anota, Amélie

Bonnetain, Franck
License Information

Text and Data Mining valid from 2019-04-16
More Information

Article History

Received: 4 October 2017

Accepted: 4 April 2019

First Online: 16 April 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.